Hitoe Torisu‐Itakura

810 total citations
35 papers, 619 citations indexed

About

Hitoe Torisu‐Itakura is a scholar working on Immunology, Dermatology and Oncology. According to data from OpenAlex, Hitoe Torisu‐Itakura has authored 35 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 16 papers in Dermatology and 12 papers in Oncology. Recurrent topics in Hitoe Torisu‐Itakura's work include Dermatology and Skin Diseases (15 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Immunotherapy and Immune Responses (7 papers). Hitoe Torisu‐Itakura is often cited by papers focused on Dermatology and Skin Diseases (15 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Immunotherapy and Immune Responses (7 papers). Hitoe Torisu‐Itakura collaborates with scholars based in United States, Japan and United Kingdom. Hitoe Torisu‐Itakura's co-authors include Donald L. Morton, Richard Essner, Jonathan Lee, Leslie A. Wanek, Hong Wang, Michihiko Kuwano, Masutaka Furue, Mayumi Ono, Yukari Okubo and Yoji Morisaki and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Hitoe Torisu‐Itakura

34 papers receiving 615 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hitoe Torisu‐Itakura	306	256	199	119	90	35	619
Francis Bonnefoy	408 1.3×	82 0.3×	49 0.2×	152 1.3×	49 0.5×	29	616
Nora Ratcliffe	166 0.5×	96 0.4×	60 0.3×	77 0.6×	122 1.4×	21	443
Émmanuelle Vigarios	97 0.3×	402 1.6×	193 1.0×	119 1.0×	94 1.0×	39	729
Paolo Del Fiore	74 0.2×	333 1.3×	57 0.3×	103 0.9×	75 0.8×	78	539
Qiang Shu	363 1.2×	122 0.5×	34 0.2×	245 2.1×	77 0.9×	51	706
Elyssa Ott	199 0.7×	85 0.3×	71 0.4×	88 0.7×	101 1.1×	14	491
Giovanna Motta	187 0.6×	225 0.9×	80 0.4×	132 1.1×	56 0.6×	45	621
Katarzyna Romanowska‐Próchnicka	230 0.8×	81 0.3×	55 0.3×	142 1.2×	81 0.9×	37	644
Winifred Werther	145 0.5×	128 0.5×	38 0.2×	161 1.4×	33 0.4×	27	568
Haizhen Yang	221 0.7×	49 0.2×	58 0.3×	102 0.9×	53 0.6×	25	475

Countries citing papers authored by Hitoe Torisu‐Itakura

Since Specialization

Citations

This map shows the geographic impact of Hitoe Torisu‐Itakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoe Torisu‐Itakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoe Torisu‐Itakura more than expected).

Fields of papers citing papers by Hitoe Torisu‐Itakura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoe Torisu‐Itakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoe Torisu‐Itakura. The network helps show where Hitoe Torisu‐Itakura may publish in the future.

Co-authorship network of co-authors of Hitoe Torisu‐Itakura

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoe Torisu‐Itakura. A scholar is included among the top collaborators of Hitoe Torisu‐Itakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoe Torisu‐Itakura. Hitoe Torisu‐Itakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torii, Hideshi, Akimichi Morita, Chie Yamamoto, et al.. (2025). Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post‐marketing surveillance. The Journal of Dermatology. 52(5). 787–801. 1 indexed citations

Otsuka, Atsushi, Chaochen Wang, Hitoe Torisu‐Itakura, et al.. (2024). Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan. International Journal of Dermatology. 63(11). e322–e334. 2 indexed citations

Tanaka, Akio, Hidetoshi Takahashi, Ryosuke Shimizu, et al.. (2024). Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J). British Journal of Dermatology. 192(4). 597–610. 2 indexed citations

Tanaka, Akio, Ken Igawa, Hidetoshi Takahashi, et al.. (2024). Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis. Acta Dermato Venereologica. 104. adv34375–adv34375. 7 indexed citations

Shapiro, Jerry, Justin Ko, Alexander Egeberg, et al.. (2023). 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. Journal of the American Academy of Dermatology. 89(3). AB127–AB127. 1 indexed citations

Wang, Chaochen, Hitoe Torisu‐Itakura, Takao Hanada, et al.. (2023). Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study. Journal of Dermatological Treatment. 34(1). 2229465–2229465. 5 indexed citations

Soung, Jennifer, Vivian Laquer, Seth Forman, et al.. (2023). LB1702 Lebrikizumab does not impact vaccine-induced immune responses: Results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis. Journal of Investigative Dermatology. 143(9). B15–B15. 2 indexed citations

Shimomura, Yutaka, Taisuke Ito, Yoshitaka Isaka, et al.. (2022). Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib. The Nishinihon Journal of Dermatology. 84(6). 491–498.

Katoh, Norito, et al.. (2022). Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials. Dermatology and Therapy. 12(12). 2765–2779. 5 indexed citations

10.

Macey, Jake, Helen Kitchen, Natalie V. J. Aldhouse, et al.. (2021). Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan. Dermatology and Therapy. 11(2). 433–447. 16 indexed citations

11.

Okubo, Yukari, Ann Tang, Sachie Inoue, Hitoe Torisu‐Itakura, & Mamitaro Ohtsuki. (2021). Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan. Journal of Clinical Medicine. 10(24). 5732–5732. 4 indexed citations

12.

Morita, Akimichi, Yukari Okubo, Yoji Morisaki, Hitoe Torisu‐Itakura, & Yoshinori Umezawa. (2021). Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis. Dermatology and Therapy. 12(2). 481–494. 22 indexed citations

13.

Honma, Masaru, et al.. (2020). Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J). Dermatology and Therapy. 10(6). 1397–1404. 9 indexed citations

14.

Umezawa, Yoshinori, Hitoe Torisu‐Itakura, Yoji Morisaki, et al.. (2018). Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab. Journal of the European Academy of Dermatology and Venereology. 33(3). 568–576. 28 indexed citations

15.

Flaherty, Devin C., Simon Lavotshkin, Hitoe Torisu‐Itakura, et al.. (2016). Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial. Journal of the American College of Surgeons. 223(1). 134–140. 24 indexed citations

16.

Lavotshkin, Simon, Hitoe Torisu‐Itakura, Junko Ozao‐Choy, et al.. (2015). Immunoprofiling for Prognostic Assessment of Colon Cancer: a Novel Complement to Ultrastaging. Journal of Gastrointestinal Surgery. 19(6). 999–1006. 15 indexed citations

17.

Torisu‐Itakura, Hitoe, Myung‐Shin Sim, Reiko F. Irie, et al.. (2011). Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T Cells. Journal of Immunotherapy. 34(8). 597–605. 33 indexed citations

18.

Torisu‐Itakura, Hitoe, et al.. (2007). Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients. Journal of Immunotherapy. 30(8). 831–838. 36 indexed citations

19.

Torisu‐Itakura, Hitoe, Jonathan Lee, Randall P. Scheri, et al.. (2007). Molecular Characterization of Inflammatory Genes in Sentinel and Nonsentinel Nodes in Melanoma. Clinical Cancer Research. 13(11). 3125–3132. 33 indexed citations

20.

Torisu‐Itakura, Hitoe, Masutaka Furue, Michihiko Kuwano, & Mayumi Ono. (2000). Co‐expression of Thymidine Phosphorylase and Heme Oxygenase‐1 in Macrophages in Human Malignant Vertical Growth Melanomas. Japanese Journal of Cancer Research. 91(9). 906–910. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact